We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

44 hedge funds and large institutions have $224M invested in Aura Biosciences in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 5

29% more funds holding

Funds holding: 34 → 44 (+10)

7.08% more ownership

Funds ownership: 46.9% → 53.98% (+7.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

25% less capital invested

Capital invested by funds: $299M → $224M (-$75M)

Holders
44
Holders Change
+10
Holders Change %
+29.41%
% of All Funds
0.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
24
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.1M
2
RCM
Regency Capital Management
Hawaii
+$4.21M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.42M
4
State Street
State Street
Massachusetts
+$2.84M
5
Citigroup
Citigroup
New York
+$2.03M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$338K
2
Barclays
Barclays
United Kingdom
-$290K
3
Citadel Advisors
Citadel Advisors
Florida
-$74.4K
4
Wells Fargo
Wells Fargo
California
-$13.1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$231K +$258K +15,566 +2,064%
WIC
27
Water Island Capital
New York
$206K +$241K +14,541 New
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$203K +$134K +8,100 +130%
CAPTRUST Financial Advisors
29
CAPTRUST Financial Advisors
North Carolina
$190K +$222K +13,414 New
MIM
30
MetLife Investment Management
New Jersey
$156K +$182K +11,026 New
JP Morgan Chase
31
JP Morgan Chase
New York
$139K +$119K +7,170 +273%
Deutsche Bank
32
Deutsche Bank
Germany
$131K +$104K +6,311 +214%
AIG
33
American International Group
New York
$122K +$95.9K +5,795 +208%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$111K +$90.7K +5,478 +232%
TRCT
35
Tower Research Capital (TRC)
New York
$56K +$47K +2,840 +256%
AB
36
Amalgamated Bank
New York
$41K +$34.8K +2,105 +266%
AIP
37
Ameritas Investment Partners
Nebraska
$19K +$15.8K +953 +226%
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$18.1K +$21.2K +1,280 New
SO
39
STRS Ohio
Ohio
$18K – – –
Legal & General Group
40
Legal & General Group
United Kingdom
$12K +$5.96K +360 +72%
SSG
41
Summit Securities Group
New York
$11K +$12.4K +750 New
Wells Fargo
42
Wells Fargo
California
$6K -$13.1K -791 -65%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$1K -$4K -242 -70%
CS
44
Credit Suisse
Switzerland
– +$199 +12 New
1
2

AURA Hedge Fund Activity: Q2 2022 in Review

44 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2022, worth a combined $224M — down 25% from $299M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AURA positions and 0 closed out — a net gain of 11 holders — while 24 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock, adding an estimated $10.1M. The largest seller was Adage Capital Partners, cutting an estimated $338K.

  • 44 institutional investors held Aura Biosciences (AURA) as of Q2 2022, up from 34 in Q1 2022.
  • Funds reported $224M of Aura Biosciences stock for Q2 2022, down 25% quarter-over-quarter.
  • 11 funds opened new Aura Biosciences positions in Q2 2022 and 0 closed out, a net change of +11 holders.
  • The largest Aura Biosciences buyer in Q2 2022 was BlackRock, an estimated $10.1M added.
  • The largest Aura Biosciences seller in Q2 2022 was Adage Capital Partners, an estimated $338K sold.

Based on aggregated 13F filings for Q2 2022.